Our study demonstrates that hypofractionated adjuvant chest wall radiation therapy using a telecobalt machine is associated with a low incidence of severe acute skin reactions and odynophagia. The regimen appears to be well-tolerated, with minimal impact on weight and nutritional status.
Manjunath et al. (Thu,) studied this question.